ISM 2026 Confirmed Speakers
Shaping the Future of Microbiota Medicine: From Mechanisms to PreventionAlain Stintzi, University of Ottawa, Canada | The Presidential Lecture of the International Society of Microbiota
Smoking, Microbiota and Immunity: Solving a 40-Year Clinical ParadoxHiroshi Ohno, RIKEN Center for Integrative Medical Sciences, Japan
The Next Frontier in GeroMedicine: Programming the Microbiome for Healthy LongevitySoheil Saeedi, University of Zurich, Switzerland
Digital Microbiology and Next-Generation Sequencing: Harnessing Clinical Metagenomics for Precision MedicineAshley Rooney, University of Zurich, Switzerland
Can the Microbiome Become a Standard Component of Precision Oncology?Meriem Messaoudene, University of Montreal, Canada
Early-Life Microbiota: Shaping Immunity, Lifelong Health and Disease RiskMercedes Gomez de Agüero Tamargo, Universität Würzburg, Germany
Beyond the Gut: Microbiota-Derived Bile Acids in Tissue Immunity and InflammationTomasz Wypych, Nencki Institute of Experimental Biology PAS, Poland
Harnessing the Gut Microbiome to Unlock Anti-Tumor ImmunityZe'ev Ronai, Cedars-Sinai Health Sciences University, USA
Maternal-Fetal Microbiome Profiling and Precision Medicine: From Biomarker Discovery to Clinical Translation Souhaila Al Khodor, Sidra Medicine, Qatar
Human Microbiome in Parkinson’s Disease: Identifying Causal Molecules for Early Diagnostics and Targeted InterventionsPaul Wilmes, University of Luxembourg, Luxembourg
From Gut to Gametes: Microbial Metabolites Shaping Male FertilityCristian O’Flaherty, McGill University, Canada
Uncovering the roles of gut fungi using shotgun sequencing dataVirginia Pedicord, University of Cambridge, United Kingdom
Can a Microbial Metabolite Extend Health and Lifespan? The Butyrate–Mitochondria ConnectionEnrique Gabandé Rodríguez, CBM Severo Ochoa, Spain
From Population Science To Personalised Nutrition: Microbial Metabolites As The Functional Link Between Diet, The Gut Microbiome And HealthCristina Menni, King's College London, UK & University of Milan, Italy
From Mucosal Inflammation to Malignancy: Deciphering the Microbiome at the Crossroads of IBD and Colorectal CancerMichael Scharl, University of Zurich, Switzerland
